An inflammatory pseudotumor of the liver in a patient with reactive arthritis

T. Matoba; M. Higuchi; N. Yamashita; S. Yoshizawa; H. Nishizaka; T. Horiuchi; H. Ishibashi; Y. Niho

doi:10.3109/bf03041285

An inflammatory pseudotumor of the liver in a patient with reactive arthritis

T. Matoba, M. Higuchi, N. Yamashita, S. Yoshizawa, H. Nishizaka, T. Horiuchi, H. Ishibashi, Y. Niho

Internal Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

A rare case of an inflammatory pseudotumor (IPT) of the liver with reactive arthritis (ReA) is herein described. A 34-year-old woman presented with post-infectious ReA in the bilateral knees and foot joints. As the primary infected site for ReA could not be determined, a systemic survey revealed an IPT in her liver, which was diagnosed histologically. The arthritis and the tumor regressed simultaneously after being treated by indomethacin farnesil 400 mg/day. Although the exact etiology of IPT or ReA still remains unknown, it is hypothesized that the same pathogenetic mechanisms may be involved in the development of IPT and ReA.

Original language	English
Pages (from-to)	273-282
Number of pages	10
Journal	Japanese Journal of Rheumatology
Volume	9
Issue number	3
DOIs	https://doi.org/10.3109/bf03041285
Publication status	Published - 1999

All Science Journal Classification (ASJC) codes

Rheumatology

Access to Document

10.3109/bf03041285

Fingerprint Dive into the research topics of 'An inflammatory pseudotumor of the liver in a patient with reactive arthritis'. Together they form a unique fingerprint.

Cite this

@article{72dbb44d5d0f4009a91717b0e2bba54c,

title = "An inflammatory pseudotumor of the liver in a patient with reactive arthritis",

abstract = "A rare case of an inflammatory pseudotumor (IPT) of the liver with reactive arthritis (ReA) is herein described. A 34-year-old woman presented with post-infectious ReA in the bilateral knees and foot joints. As the primary infected site for ReA could not be determined, a systemic survey revealed an IPT in her liver, which was diagnosed histologically. The arthritis and the tumor regressed simultaneously after being treated by indomethacin farnesil 400 mg/day. Although the exact etiology of IPT or ReA still remains unknown, it is hypothesized that the same pathogenetic mechanisms may be involved in the development of IPT and ReA.",

author = "T. Matoba and M. Higuchi and N. Yamashita and S. Yoshizawa and H. Nishizaka and T. Horiuchi and H. Ishibashi and Y. Niho",

year = "1999",

doi = "10.3109/bf03041285",

language = "English",

volume = "9",

pages = "273--282",

journal = "Modern Rheumatology",

issn = "1439-7595",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - An inflammatory pseudotumor of the liver in a patient with reactive arthritis

AU - Matoba, T.

AU - Higuchi, M.

AU - Yamashita, N.

AU - Yoshizawa, S.

AU - Nishizaka, H.

AU - Horiuchi, T.

AU - Ishibashi, H.

AU - Niho, Y.

PY - 1999

Y1 - 1999

N2 - A rare case of an inflammatory pseudotumor (IPT) of the liver with reactive arthritis (ReA) is herein described. A 34-year-old woman presented with post-infectious ReA in the bilateral knees and foot joints. As the primary infected site for ReA could not be determined, a systemic survey revealed an IPT in her liver, which was diagnosed histologically. The arthritis and the tumor regressed simultaneously after being treated by indomethacin farnesil 400 mg/day. Although the exact etiology of IPT or ReA still remains unknown, it is hypothesized that the same pathogenetic mechanisms may be involved in the development of IPT and ReA.

AB - A rare case of an inflammatory pseudotumor (IPT) of the liver with reactive arthritis (ReA) is herein described. A 34-year-old woman presented with post-infectious ReA in the bilateral knees and foot joints. As the primary infected site for ReA could not be determined, a systemic survey revealed an IPT in her liver, which was diagnosed histologically. The arthritis and the tumor regressed simultaneously after being treated by indomethacin farnesil 400 mg/day. Although the exact etiology of IPT or ReA still remains unknown, it is hypothesized that the same pathogenetic mechanisms may be involved in the development of IPT and ReA.

UR - http://www.scopus.com/inward/record.url?scp=0032846965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032846965&partnerID=8YFLogxK

U2 - 10.3109/bf03041285

DO - 10.3109/bf03041285

M3 - Article

AN - SCOPUS:0032846965

VL - 9

SP - 273

EP - 282

JO - Modern Rheumatology

JF - Modern Rheumatology

SN - 1439-7595

IS - 3

ER -